These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 13861221)

  • 21. Azaserine: pathological and pharmacological studies.
    STERNBERG SS; PHILIPS FS
    Cancer; 1957; 10(5):889-901. PubMed ID: 13472634
    [No Abstract]   [Full Text] [Related]  

  • 22. EXPERIMENTAL CHEMOTHERAPY STUDIES. V. THE COLLATERAL SENSITIVITY TO ALKYLATING AGENTS OF SEVERAL ANTIMETABOLITE-RESISTANT ASCITES TUMORS IN MICE.
    RUTMAN RJ
    Cancer Res; 1964 May; 24():634-8. PubMed ID: 14188466
    [No Abstract]   [Full Text] [Related]  

  • 23. BIOCHEMISTRY OF CANCER (METABOLIC ASPECTS).
    BROCKMAN RW; ANDERSON EP
    Annu Rev Biochem; 1963; 32():463-512. PubMed ID: 14144487
    [No Abstract]   [Full Text] [Related]  

  • 24. [In vitro effects of azaserine on normal and neoplastic tissue; polarographic behavior of azaserine].
    SANTAMARIA L
    Farmaco Sci; 1955; 10(11):897-909. PubMed ID: 13294172
    [No Abstract]   [Full Text] [Related]  

  • 25. Antineoplastic activity of combinations of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Cancer Res; 1960 Feb; 20():198-203. PubMed ID: 14441824
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of ascites tumour growth by the trypanocide, ethidium bromide, in combination with azaserine.
    KANDASWAMY TS; HENDERSON JF
    Nature; 1962 Jul; 195():85. PubMed ID: 14453546
    [No Abstract]   [Full Text] [Related]  

  • 27. Concentrative uptake of azaserine by neoplastic plasma cells and lymphocytes.
    PINE EK
    J Natl Cancer Inst; 1958 Nov; 21(5):973-84. PubMed ID: 13599021
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of the biosynthesis of purines de novo by 6-chloropurine and azaserine in sensitive and naturally resistant ascites cells.
    SARTORELLI AC; AKERS JR; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():238-44. PubMed ID: 13746609
    [No Abstract]   [Full Text] [Related]  

  • 29. Utilization of preformed purines by sarcoma 180 or hepatoma 134 cells treated with 6-chloropurine or a combination of 6-chloropurine and azaserine.
    SARTORELLI AC; BOOTH BA
    Biochem Pharmacol; 1960 Nov; 5():245-50. PubMed ID: 13746610
    [No Abstract]   [Full Text] [Related]  

  • 30. HOST-TUMOR-DRUG RELATIONSHIPS IN EXPERIMENTAL CHEMOTHERAPY SYSTEMS WITH ALLOGENEIC AND XENOGENEIC HOST-TUMOR COMBINATIONS.
    TELLER MN; WOLFF R; WAGSHUL SF
    Cancer Res; 1964 Jan; 24():114-9. PubMed ID: 14106153
    [No Abstract]   [Full Text] [Related]  

  • 31. SOME METABOLIC EFFECTS EXERTED BY AZASERINE AND PURINE ANALOGS IN VIVO.
    SARTORELLI AC; UPCHURCH HF; BIEBER AL; BOOTH BA
    Cancer Res; 1964 Aug; 24():1202-9. PubMed ID: 14216152
    [No Abstract]   [Full Text] [Related]  

  • 32. The development and biochemical characterization of resistance to azaserine in a TA 3 ascites carcinoma.
    SARTORELLI AC; LePAGE GA
    Cancer Res; 1958 May; 18(4):457-63. PubMed ID: 13536997
    [No Abstract]   [Full Text] [Related]  

  • 33. Adenocarcinoma of the pancreas in azaserine-treated rats.
    Longnecker DS; Curphey TJ
    Cancer Res; 1975 Aug; 35(8):2249-58. PubMed ID: 1097106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of histidine and its metabolites on the biosynthesis of purines by Escherichia coli B. IV. Action on some cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 14400512
    [No Abstract]   [Full Text] [Related]  

  • 35. Cytochemical effects of azaserine and DON on ribonucleic acid of Ehrlich ascites tumor cells.
    LINDNER A; LARSEN A
    AMA Arch Pathol; 1958 Apr; 65(4):415-9. PubMed ID: 13520053
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influence of histidine and of its metabolites on the biosynthesis of purines by Escherichia coli B. V. Mode of action in cultures inhibited by azaserine].
    HEDEGAARD J; MASPERO-SEGRE S; NGUYEN VAN THOAI ; ROCHE J
    C R Seances Soc Biol Fil; 1959; 153():767-71. PubMed ID: 13848416
    [No Abstract]   [Full Text] [Related]  

  • 37. Action of azaserine on Escherichia coli.
    KAPLAN L; REILLY HC; STOCK CC
    J Bacteriol; 1959 Oct; 78(4):511-9. PubMed ID: 14404400
    [No Abstract]   [Full Text] [Related]  

  • 38. Early cell death due to azaserine treatment of Ehrlich ascites tumor cells: a histochemical comparison of histone with DNA and total protein.
    LINDNER A
    Acta Unio Int Contra Cancrum; 1960; 16():691-5. PubMed ID: 14417174
    [No Abstract]   [Full Text] [Related]  

  • 39. [Research on the cytological modalities and the biochemical mechanism of the activity of the inhibitors of nucleic metabolism: diaza-oxo-norleucine and azaserine].
    TRUHAUT R; DEYSSON G
    Bull Soc Chim Biol (Paris); 1961; 43():227-38. PubMed ID: 13778269
    [No Abstract]   [Full Text] [Related]  

  • 40. Chemotherapy of sarcoma 180 by combinations of DL-glyceraldehyde with 6-thioguanine or with azaserine and 6-chloro-purine.
    SARTORELLI AC; SCHOOLAR EJ; KRUSE PF
    Proc Soc Exp Biol Med; 1960 Jun; 104():266-8. PubMed ID: 14441826
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.